CompletedNot Applicable

Remote Guided Caffeine Reduction

United States109 participantsStarted 2020-09-10

Plain-language summary

The purpose of this online research study is to determine whether or not a gradual caffeine reduction program developed at Johns Hopkins can help people reduce their caffeine use. The investigators will provide materials to help guide caffeine reduction and ask questions to track caffeine use over several weeks. The investigators will also assess how reducing caffeine may benefit common caffeine-related problems such as anxiety, sleep disturbances, and gastrointestinal distress. The study will also determine whether or not people like participating in this caffeine reduction program in an online format.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18-75 years old * Reside in the United States * Read, write, and speak English fluently * Able to access a video camera on a smart phone, tablet, or other computer * Able to receive text messages or emails (or both) * Suitable caffeine consumption * Indicate suitable reason for caffeine reduction * Interested in getting help to gradually reduce or eliminate caffeine consumption as part of a research study Exclusion Criteria: * Any current medical or psychiatric disorder or symptoms that, in the opinion of the investigators, may interfere with or preclude completion of the study \[many psychiatric or medical concerns such as insomnia or anxiety are not anticipated to interfere with study participation and will not generally be exclusionary\]

What they're measuring

Number of Participants With Treatment Retention as Assessed by Number of Participants With Completed Assessments

Timeframe: Treatment Visit, 7-Week Follow-Up, 14-Week Follow-Up

Treatment Acceptability as Assessed by Treatment Acceptability Questionnaire

Timeframe: 7 weeks Follow-Up visit

Trial details

NCT IDNCT04560595

SponsorJohns Hopkins University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-01

Results submitted2024-12-03